一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Anti-PRKAA1 Monoclonal Antibody,Anti-PRKAA1 Monoclonal Antibody
  • Anti-PRKAA1 Monoclonal Antibody,Anti-PRKAA1 Monoclonal Antibody

Anti-PRKAA1 Monoclonal Antibody

價(jià)格 1600.00 960.00
包裝 100ul 50ul
最小起訂量 50ul
發(fā)貨地 北京
更新日期 2026-06-11
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:Anti-PRKAA1 Monoclonal Antibody英文名稱:Anti-PRKAA1 Monoclonal Antibody
Gene ID: 5562Public Immunogen Range: Synthetic Peptide
Subcellular Locations: Cytoplasm NucleusSwiss Prot: Q13131
保存: Store at -20°C. Avoid freeze / thaw cycles.別名: AMPK;AMPKa1
產(chǎn)品編號(hào): K000238M儲(chǔ)存液: Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
純化方法: Saturated ammonium sulfate precipitation蛋白分子量: 64/66kDa
克隆號(hào): 5G11克隆類型: Monoclonal Antibody
免疫原: Synthetic Peptide品牌: solarbio
宿主: Mouse稀釋比例: WB 1:1000-2000. IHC 1:100-200.
性狀: 液體亞型: IgG1
應(yīng)用: WB IHC英文名稱: Anti-PRKAA1 Monoclonal Antibody
2026-06-11 Anti-PRKAA1 Monoclonal Antibody Anti-PRKAA1 Monoclonal Antibody 100ul/1600.00RMB;50ul/960.00RMB 1600.00

背景資料

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.
關(guān)鍵字: Anti-PRKAA1 Monoclonal Antibody;抗體

公司簡介

北京索萊寶科技有限公司是一家集研發(fā)、生產(chǎn)、銷售、服務(wù)于一體的高科技生物企業(yè)。技術(shù)推廣;技術(shù)轉(zhuǎn)讓;技術(shù)咨詢;技術(shù)服務(wù);生物試劑技術(shù)開發(fā);銷售生物試劑盒、實(shí)驗(yàn)室專用化學(xué)試劑、實(shí)驗(yàn)室專用設(shè)備、辦公用品、化工產(chǎn)品(不含危險(xiǎn)化學(xué)品)、計(jì)算機(jī)軟件及輔助設(shè)備;貨物進(jìn)出口、技術(shù)進(jìn)出口、代理進(jìn)出口;委托加工生產(chǎn)生物制品、生化制品、化工產(chǎn)品(不含危險(xiǎn)化學(xué)品);生產(chǎn)生物試劑盒;批發(fā)第一類醫(yī)療器械、第二類醫(yī)療器械;批發(fā)第三類醫(yī)療器械。
成立日期 2004-09-22 (22年) 注冊(cè)資本 4001萬元
員工人數(shù) 100-500人 年?duì)I業(yè)額 ¥ 500萬-1000萬
主營行業(yè) 分析化學(xué),生物化工,化學(xué)試劑,醫(yī)藥原料,儀器耗材 經(jīng)營模式 貿(mào)易,工廠,試劑
  • 北京索萊寶科技有限公司
VIP 10年
  • 公司成立:22年
  • 注冊(cè)資本:4001萬元
  • 企業(yè)類型:有限責(zé)任公司
  • 主營產(chǎn)品:小分子化合物、分析對(duì)照品、染色試劑、生化試劑盒、細(xì)胞生物學(xué)、分子生物學(xué)、抗體、蛋白、多肽、ELISA試劑盒、微生物培養(yǎng)、化學(xué)合成、儀器耗材、CRO技術(shù)服務(wù)、生化試劑等
  • 公司地址:北京市北京經(jīng)濟(jì)技術(shù)開發(fā)區(qū)環(huán)科中路16號(hào)26幢3層301
詢盤

Anti-PRKAA1 Monoclonal Antibody相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
¥920
VIP7年
愛必信(上海)生物科技有限公司
2026-06-12
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁 | 企業(yè)會(huì)員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號(hào)  京公海網(wǎng)安備110108000080號(hào)  All rights reserved.
新闻| 樟树市| 泾源县| 苗栗县| 望奎县| 左权县| 高阳县| 海南省| 肇源县| 兴国县| 台东县| 阿拉善盟| 宽城| 万州区| 仙居县| 普定县| 富顺县| 公主岭市| 什邡市| 五指山市| 东安县| 耒阳市| 四会市| 滨海县| 辽阳县| 砚山县| 大丰市| 昌黎县| 新河县| 灵山县| 商都县| 北流市| 玛沁县| 张家川| 施甸县| 晋州市| 广州市| 沛县| 四川省| 彭阳县| 集安市|